Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: A case control study

BMC Infectious Diseases

Volumn 3, Issue , 2003, Pages

  Wojcicki, Janet M ^a   Newton, Rob ^b   Urban, Margaret I ^c   Stein, Lara ^c   Hale, Martin ^d   Patel, Moosa ^d,e   Ruff, Paul ^d,h   Sur, Ranjan ^d,f   Bourboulia, Dimitra ⁱ   Sitas, Freddy ^c,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c S African Can Epidemiol Res Group   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f MCMASTER UNIVERSITY   (Canada)

^g CANCER RESEARCH DIVISION   (Australia)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; COAL; FUEL; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; BEER; BLOOD ANALYSIS; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; COOKING; DEMOGRAPHY; DIVORCE; ELECTRICITY; FEMALE; FOOD INTAKE; HERPES; HOSPITAL PATIENT; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; INTERVIEW; KAPOSI SARCOMA; LOGISTIC REGRESSION ANALYSIS; MAIZE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE ANALYSIS; NEGRO; PREVALENCE; SOCIAL ASPECT; SOUTH AFRICA; WOOD;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 8, HUMAN; HIV SERONEGATIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SARCOMA, KAPOSI; SOUTH AFRICA;

EID: 2442644091     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-3-21     Document Type: Article

References (42)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM and Moore PS: Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-9.
2. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y and Moore PS: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2:925-8.
3. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS and Schulz TF: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346:799-802.
4. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA and O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995, 1:1274-8.
5. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D and Haase AT: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997, 71:715-9.
6. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW and Chang Y: Kaposi's sarcoma-associated herpesviurs infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10:175-180.
7. Dedicoat M and Newton R: Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. British Journal of Cancer 2003, 88:1-3.
8. Grossman Z, Iscovich J, Schwartz F, Azizi E, Klepfish A, Schattner A and Sarid R: Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc 2002, 77(9):905-9.
9. Greenblatt R: Kaposi's sarcoma and human herpesvirus-8. Infect Dis Clin North Am 1998, 12(1):63-82.
10. Iscovich J, Boffetta P, Franceschi S, Azizi E and Sarid R: Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 2000, 88(3):500-17.
11. Ziegler JL, Newton R, Katongole-Mbidde E, Mbulataiye S, De Cock K, Wabinga H, Mugerwa J, Katabira E, Jaffe H, Parkin DM, Reeves G, Weiss R and Beral V: Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS 1997, 11:1619-1626.
12. Ziegler JL, Simonart T and Snoeck R: Kaposi's saroma, oncogenic viruses and iron. Journal of Clinical Virology 2001, 20:127-130.
13. Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C and Uganda Kaposi's Sarcoma Study Group: Risk factors for Kaposi's sarcoma: A Case-control study of HIV-seronegative people in Uganda. International Journal of Cancer 2003, 103:233-240.
14. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C and Weiss R: Antibodies against human herpesvirus 8 in black South African patients with cancer. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999, 340(24):1863-71.
15. Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristera R, Aiuti F, Ortona L and Ensoli B: Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999, 91(17):1468-74.
16. Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P and Dillner J: Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma. J Clin Microbiol 2001, 39(12):4269-73.
17. Biggar RJ, Engels EA, Whitby D, Kedes DH and Goedert JJ: Antibody Reactivity to Latent and Lytic Antigens to Human Hepesvirus-8 in Longitudinally Followed Homosexual Men. Journal of Infectious Disease 2003, 187:1218.
18. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C and Uganda Kaposi's Sarcoma Study Group: The seroepidemiology of Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. International Journal of Cancer 2003, 103:226-232.
19. Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C and Uganda Kaposi's Sarcoma Study Group: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 1998, 91:1671-9.
20. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA and Moore PS: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348:1133-8.
21. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J and Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2:918-924. [Erratum, Nat Med 1996; 2: 1041]
22. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS and Schulz TF: The 222 to 234-kilodalton laten nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virology 1997, 71:5915-5921.
23. Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA and Talbot SJ: Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virology 1997, 1:19-29.
24. Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA and Chang Y: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 1998, 91:1671-1679.
25. Renwick H, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF and Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12(18):2481-8.
26. STATA: Stata software. College Park, TX: STATA 2001.
27. Lemeshow S and Hosmer DW Jr: A Review of goodness of fit statistics for use in the development of logistic regression models. American Journal of Epidemiology 1982, 115:92-106.
28. de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P and Henle W: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978, 274:756-61.
29. de-The G, Lavoue MF and Muenz L: Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. In: Nasopharyngeal carcinoma: etiology and control Edited by: de-The, Ito Y. Lyons, France: International Agency for Research on Cancer, (IARC scientific publications no.20.); 1978.
30. Cook-Mozaffari P, Newton R, Beral V and Burkitt DP: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998, 78:1521-8.
31. Plancoulaine S, Abel L, van Beveren M and Gessain A: High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. Journal of the National Cancer Institute 2002, 94(7):133-5.
32. Vitale F, Briffa DV, Whitby D, Maida I, Grochowska A, Levin A, Romano N and Goedert JJ: Annual Incidence Rates of Classical KS in 3 Mediterranean Islands. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. International Journal of Cancer 2001, 91:588-591.
33. Serraino D, Corona RM, Giuliani M, Farchi F, Sarmati L and Uccella I et al.: Infection with Human Herpesvirus Type 8 and Kaposi's Sarcoma in a Central Italian Area Formerly Endemic for Malaria. Infection 2003, 31(1):47-50.
34. Statistics South Africa: Census in Brief. Pretoria: Statistics - SA 1996.
35. Stowe RP, Pierson DL, Feeback DL and Barrett AD: Stress-induced reactivation of Epstein-Barr virus in astronauts. Neuroimmunomodulation 2000, 8(2):51-8.
36. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA and Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15(3):199-226.
37. Gordeuk VR and Brittenham GML: Iron overload - still a problem among the Zulus. South African Medical Journal 1986:603-4.
38. Bothwell TH, Seftel H, Jacobs P, Torrance JD and Baumslag N: Iron overload in Bantu subjects. American Journal of Clinical Nutrition 1964, 14:47-51.
39. Baker LD: Alcohol consumption among South African blacks and its relationship to iron overload. South African Medical Journal 1986, 70:160-2.
40. Bothwell TH, Charlton RW and Sewftel HC: Oral iron overload. South African Medical Journal 1965:892-900.
41. Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, Romano N and Classical Kaposi's Sarcoma Working Group: Risk factors for classical Kaposi's sarcoma. Journal of the National Cancer Institute 2002, 94(22):1712-8.
42. Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, Macfarlane BJ, Lamparelli RD, Robinson EJ, Sher R and Hamberg S: Dietary iron overload in southern African rural blacks. South African Medical Journal 1990, 78:301-5.